STAHL NEIL sold REGN

February 7, 2024 · Form 4 insider transaction

STAHL NEIL sold 3,127 shares of Regeneron Pharmaceuticals, Inc. at $950.43 per share, a transaction worth $2.97M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
3,127
Price
$950.43
Total value
$2.97M
InsiderSTAHL NEIL
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 7, 2024
Filing dateFebruary 8, 2024
Shares owned after54,334
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.

View the original Form 4 on SEC EDGAR
STAHL NEIL sold REGN: February 7, 2024 | Insider Trading Screener